Searched for
INDIAN PHARMA COMPANIES
More than family business: Drugmakers make costly, long-term strategic shifts as next generation steps into bigger rolesIndia's family-run pharmaceutical companies are entering a new phase as the next generation takes on larger leadership roles and steers bus...- Samir Arora backed Helios Mid Cap Fund adds Aurobindo Pharma, 2 others, increase stake in Paytm, MCX and 16 othersSamir Arora-backed Helios Mid Cap Fund added Aurobindo Pharma, Zetwerk and PVR Inox in October, while increasing stakes in Paytm, MCX and 1...
- FDA flags persistent data-integrity lapses, insanitary conditions at Indian drug facilitiesThe US FDA continues to identify serious data integrity issues in Indian pharmaceutical manufacturing facilities. During inspections, inspe...
- Stocks in news: Bharti Airtel, LIC, Titan, ONGC, Bharti Hexacom, Glenmark Pharma and AstralIndian equity markets continued their upward trend, highlighted by the Nifty 50 gaining 576 points. Bharti Airtel, LIC, and Titan Company r...
- Ahead of Market: 10 things that will decide stock market action on FridayIndian markets staged a powerful rally, with Sensex jumping 2,009 points and Nifty gaining 576 points. Improved global sentiment, easing cr...
- Market wrap: Bajaj Finance, Shriram Finance, Apollo Hospital, ONGC top gainers and losers on Nifty and Sensex on ThursdayIndian equity markets staged a strong rally on Thursday, with the Sensex surging over 2,000 points and the Nifty jumping 576 points amid op...
- Pills are paying off! Pharma stocks lead 2026 rally with up to 112% returnIn 2026, India's pharmaceutical stocks are making headlines with impressive year-to-date gains. This surge is driven by strong domestic dem...
- Stocks in news: BSE, Lenskart, Nykaa, Bharti Airtel, LIC, Aurobindo Pharma and NalcoIndian equity markets have enjoyed a remarkable stretch, registering gains for five consecutive sessions. The Nifty 50 index showed impress...
- Ahead of Market: 10 things that will decide stock market action on ThursdayIndian markets extended their rally, with Sensex gaining 384 points to 77,301 and Nifty rising 150 points to 23,961, marking two-month high...
- Wockhardt seeks 14-year data shield for India-made drugsMumbai-based Wockhardt has struck success in its innovative research on a range of antibiotic drugs, bridging a global pipeline gap for dif...
- Beyond tech: Kotak MF’s Shibani Kurian on India’s next innovation-led winnersInnovation-led investment opportunities in India are extending well beyond technology, with healthcare, auto components and industrials eme...
- FPI holding hits multi-year lows in 70% of top 100 Indian companiesForeign investors have significantly reduced their holdings in nearly 70% of India's leading companies in recent years. Major firms, includ...
- Market wrap: RIL, Tata Steel, Infosys, ICICI Bank top gainers and losers on Nifty and Sensex on MondayIndian markets rallied sharply, with Sensex gaining 1.66% to 75,693 and Nifty rising 1.68% to 23,441. Strong quarterly earnings lifted inve...
- Mold-Tek Packaging shares surge 17% as Q2 FY 27 profit jumps 35% YoY to Rs 21 croreMold-Tek Packaging shares surged nearly 17% after the company reported a 35.5% YoY rise in Q2 FY27 net profit and 30.5% revenue growth. Str...
- Diwali 2026: 77 stocks knock down D-St bears to deliver multibagger returns of up to 4,700% in a yearWith Diwali 2026 on the horizon, 77 stocks have thrived despite market fluctuations, marking exceptional returns. Mrugesh Trading showcases...
- Ahead of Market: 10 things that will decide stock market action on MondaySensex and Nifty ended the week up about 0.5%, supported by resilient large-cap, IT and healthcare stocks. However, midcap and smallcap ind...
- Sun Pharma ordered to halt eye drug production at Assam plant over quality lapses: ReportIndian regulators have ordered Sun Pharmaceutical Industries to stop manufacturing ophthalmic products at the Assam facility. This decision...
- SCHOTT Pharma India marks a new chapter, building on its strong national presence and global capabilitiesNew identity reinforces the company’s focus on innovation, customer partnerships and pharmaceutical drug containment and delivery solutions
- Ahead of Market: 10 things that will decide stock market action on ThursdayIndian markets closed lower on Wednesday as rising crude oil prices and Middle East tensions hurt sentiment. Sensex fell 353 points to 73,2...
- Piramal Pharma cutting China exposure to manage supply-chain resilience, says Nandini PiramalIn a strategic move to enhance risk management, Piramal Pharma has drastically cut its reliance on Chinese raw materials to under 10%. The ...
Load More
